Related Experiment Video
Updated: May 2, 2026
09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
39.4K
Idiotype vaccine production using hybridoma technology
Susana Inoges1, Ascensión López Díaz de Cerio, Helena Villanueva
1Immunotherapy Program, University of Navarra Hospital, Pamplona, Spain.
Methods in Molecular Biology (Clifton, N.J.)
|March 13, 2014
Summary
Idiotypic vaccination, using tumor-specific immunoglobulin, shows promise for treating follicular lymphoma (FL), a common Non-Hodgkin's lymphoma (NHL). This immunotherapy approach can induce immune responses and potentially extend disease-free survival, though further trials are needed.
Area of Science:
- Hematological Malignancies
- Immunotherapy
- Vaccine Development
Background:
- Non-Hodgkin's lymphoma (NHL) is a prevalent blood cancer, with follicular lymphoma (FL) comprising 25% of cases.
- Follicular lymphoma (FL) often relapses despite standard treatments, highlighting the need for novel therapeutic strategies.
- Immunotherapy, specifically idiotype vaccination, is an experimental approach for managing FL.
Purpose of the Study:
- To explore idiotype vaccination as a therapeutic option for follicular lymphoma (FL).
- To describe the production of idiotype vaccines using hybridoma technology.
Main Methods:
- Idiotype vaccines are generated by conjugating tumor-specific immunoglobulin with keyhole limpet hemocyanin (KLH) and an adjuvant.
- Hybridoma technology is the traditional method for producing these idiotype vaccines.
Main Results:
- Idiotype vaccination has demonstrated the ability to elicit specific immune responses in patients.
- Patients with induced immune responses showed prolonged disease-free survival compared to historical controls.
- These promising results require validation through large-scale clinical trials.
Conclusions:
- Idiotype vaccination represents a potential immunotherapy for follicular lymphoma (FL).
- The described hybridoma technology is crucial for the production of these experimental vaccines.
- Further clinical investigation is warranted to confirm the efficacy and durability of idiotype vaccination in FL treatment.
Related Concept Videos
01:31Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
01:23Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
01:36Humoral Immune Responses
66.2K
Overview
66.2K